Risk prediction of cardiovascular disease in type 2 diabetes

Diabetes Care

Volumn 31, Issue 10, 2008, Pages 2038-2043

  Cederholm, Jan ^a   Eeg Olofsson, Katarina ^b   Eliasson, Björn ^b   Zethelius, Björn ^a   Nilsson, Peter M ^c   Gudbjörnsdottir, Soffia ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; ASSOCIATION; BODY MASS; CARDIOVASCULAR RISK; DISEASE DURATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREDICTOR VARIABLE; SMOKING; STROKE; SURVIVAL RATE; SWEDEN; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; DIABETIC ANGIOPATHY; FOLLOW UP; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROBABILITY; REGISTER; RISK ASSESSMENT; SURVIVAL; TIME;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; REGISTRIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS;

EID: 56149114346     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0662     Document Type: Article

References (22)

1. Anderson KM, Odell PM, Wilson PWF, Kannel WB: Cardiovascular disease risk profiles. Am Heart] 121:293-298, 1991
2. Conroy RM, Pyöräla K, De Backer G, De Bacquer D, Wilhelmsen L, Graham IM, SCORE Project Group: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart ] 24:987-1003, 2003
3. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyorala K, DECODE Study Group, European Diabetes Epidemiology Group: Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor: the DECODE Study. Όiabetologia 47:2118-2128,2004
4. Coleman RL, Stevens RJ, Retnakaran R, Holman RR: Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 30:1292-1294, 2007
5. Gu K, Cowie C, Harris M: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21:1138-1145, 1998
6. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR: The UKPDS Risk Engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clín Scí 101:671-679, 2001
7. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR, UK Prospective Diabetes Study Group: UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33:1776-1781,2002
8. Coleman RL, Stevens RJ, Holman RR: Estimating cardiovascular disease risk for individuals with type 2 diabetes: the new UKPDS risk engine. Diabet Ued 24 (Suppl. 1):56, 2007
9. Jackson R: Cardiovascular risk prediction: are we there yet? Heart 94:1-3, 2008
10. Gudbjörnsdottir S, Cederholm J, Nilsson PM, Eliasson B: The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26:1270-1276, 2003
11. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjörnsdottir S, Swedish National Diabetes Register: Microalbumin-uria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clín Pract 67:258-266, 2005
12. Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdottir S, Swedish National Diabetes Register: The gap between guidelines and reality: type 2 diabetes in a national diabetes register 1996-2003. Diabet Med 22: 1420-1426, 2005
13. Nilsson PM, Cederholm J, Gudbjörnsdottir S, Eliasson B, Steering Committee of the Swedish National Diabetes Register: Predictors of successful long-term blood pressure control in patients with diabetes: data from the Swedish National Diabetes Register (NDR). ] Hypertens 23: 2305-2311,2005
14. Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbjörnsdottir S, Eliasson B, the Steering Committee of the Swedish National Diabetes Register: Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register. Diabetes Care 30:496-502, 2007
15. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, IFCC Working Group on A1C Standardization: IFCC reference system for measurement of hemoglobin Ale in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clín Chem 1:166-174,2004
16. Merlo J, Lindblad U, Pessah-Rasmussen H, Hedblad B, Rastam J, Isacsson SO: Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16:235-243, 2000
17. Tunstall-Pedoe H, Kuulasmaa K,Amouyel P, Arveiler D, Rajakangas AM. Pajak A: Myocardial infarction and coronary deaths in the World Health Organization MONICA project: registration procedures, events rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583-612, 1994 18. Cook NR: Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928-935, 2007
18. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Massaro JM, Kannel WB: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743-753, 2008
19. Bogers RP, Bemelmans WJE, Hoogenveen RT, Boshuizen HC, Woodward Knekt P, Shipley MJ, BMI-CHD Collaboration Investigators: Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of
20. cohort studies including more than 300 000 persons. Arch Intern Med 167: 1720-1728, 2007
21. National Institute of Clinical Excellence (NICE): Management oj Type 2 diabetes: Management oj Blood Pressure and Blood Lípíds (Guideline H). London, NICE, 2002
22. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. NEngl] Med 358:580-591, 2008